Purine Release by Human Erythrocytes

  • Alessandro Giacomello
  • Costantino Salerno
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 165)


The importance of blood and, in particular, of erythrocytes as a vehicle for transport of purines is well known1,2. Considerable quantities of purines enter and leave the nucleotide pools of red cells which take up adenine, guanine, hypoxanthine, and xanthine and convert them into nucleotides. No matter what purine is taken up by erythrocytes, hypoxanthine appears to be the main purine released in vivo. Human erythrocytes cannot synthesize purines de novo and are unable to convert hypoxanthine or guanine into adenine. Hypoxanthine release is mediated by prior conversion of the various purine nucleotides to IMP. In the present paper, some of the mechanisms which regulate the catabolic paths of this nucleotide are studied.


Human Erythrocyte Purine Nucleoside Phosphorylase Steady State Kinetic Preincubation Time Purine Release 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. W. Murray, D. C. Elliot, and M. R. Atkinson, Nucleotide Biosynthesis from preformed purines in mammalian cells, in: “Nucleic Acid Research and Molecular Biology,” J. N. Davidson and W. E. Cohn, eds., Academic Press, New York (1970).Google Scholar
  2. 2.
    A. W. Murray, The biological significance of purine salvage, Ann. Rev. Biochem. 40: 811 (1974).CrossRefGoogle Scholar
  3. 3.
    A. Giacomello and C. Salerno, Hypoxanthine uptake by human erythrocytes, Febs letters 107: 203 (1979).PubMedCrossRefGoogle Scholar
  4. 4.
    C. Salerno and A. Giacomello, Hypoxanthine transport in human erythrocytes, in: “Purine Metabolism in Man-III, Part B,” A. Rapado, R. W. E. Watts, and C. H. M. M. DeBruyn, eds., Plenum Pub. Corporation, New York (1980).Google Scholar
  5. 5.
    E. Gerlach, R. H. Dreisbach, and B. Deuticke, Paper chromatographic separation of nucleotides, nucleosides, purines, and pyrimidines, J. Chromatog. 18: 81 (1965).CrossRefGoogle Scholar
  6. 6.
    A. Giacomello and C. Salerno, Human HGPRT - Steady state kinetics of the forward and reverse reactions, J. Biol. Chem. 253: 6038 (1978).PubMedGoogle Scholar
  7. 7.
    M. R. Sheen, B. K. Kim, and R. E. Jr. Parks, Inhibition by the inosine analog formycin B of the isolated enzyme and of nucleoside metabolism in intact erythrocytes and sarcoma 180 cells, Mol. Pharmacol. 4: 293 (1968).Google Scholar
  8. 8.
    C. Salerno and A. Giacomello, Human HGPRT - IMP GMP exchange: stoichiometry and steady state kinetics of the reaction, J. Biol. Chem. 254: 10232 (1979).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Alessandro Giacomello
    • 1
  • Costantino Salerno
    • 1
  1. 1.Institutes of Rheumatology and Biological ChemistryUniversity of Rome, and Center of Molecular Biology National Research CouncilRomeItaly

Personalised recommendations